Back to companies
Emergent BioSolutions Inc.
EBSUSNYSEPharmaceuticals & HealthcareEmergent BioSolutions Inc.
Revenue
$742.9mn
YoY -28.8%
Operating income
$100.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API